Xenon Pharmaceuticals Inc (XENE) stock is up 129.60% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives XENE stock a score of 70 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 73. XENE's rank also includes a fundamental score of 71. In addition to the average rating from Wall Street analysts, XENE stock has a mean target price of $45.86. This means analysts expect the stock to add 74.89% over the next 12 months. The short-term technical score for XENE is 67.
XENE has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on XENE!
Xenon Pharmaceuticals Inc (XENE) stock is higher by 1.35% while the S&P 500 is up 0.06% as of 10:15 AM on Wednesday, Dec 8. XENE is up $0.35 from the previous closing price of $25.87 on volume of 28,852 shares. Over the past year the S&P 500 has risen 26.67% while XENE is up 129.60%. XENE lost -$1.58 per share in the over the last 12 months.
Click Here to get the full Stock Report for Xenon Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
